Abstract |
Multidrug resistance (MDR) is the major obstacle to the successful chemotherapy treatment of many cancers. Here we found that nobiletin, a citrus methoxyflavone, significantly sensitized ABCB1 overexpressing cells A2780/T and A549/T to chemotherapeutic agents such as paclitaxel (a 433-fold reversal of MDR to PTX at 9 μM), doxorubicin (DOX), docetaxel and dounorubicin. Nobiletin profoundly inhibited ABCB1 transporter activity since it significantly increased the intracellular accumulation of DOX and Flutax-2 in A2780/T cells and decreased the efflux of ABCB1 substrates in Caco2 cells without altering the mRNA and protein expression of ABCB1. Moreover, nobiletin stimulated ATPase activity and inhibited verapamil-stimulated ATPase activity in a concentration-dependent manner, indicating a direct interaction with the transporter. Consistent with these findings, molecular docking analysis also identified favorable binding of nobiletin with the transmemberane region site 1 of homology modeled human ABCB1 transporter. Moreover, the Nrf2 protein expression and phosphorylation levels of AKT/ERK were suppressed by co-treated with nobiletin and PTX at the reversal concentrations, suggesting that inhibition of the AKT/ERK/Nrf2 pathway was associated with the sensitizing effect of nobiletin. These findings encourage further animal and clinical MDR studies with the combination therapy of nobiletin and chemotherapeutic drugs.
|
Authors | Wenzhe Ma, Senling Feng, Xiaojun Yao, Zhongwen Yuan, Liang Liu, Ying Xie |
Journal | Scientific reports
(Sci Rep)
Vol. 5
Pg. 18789
(Dec 22 2015)
ISSN: 2045-2322 [Electronic] England |
PMID | 26689156
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- ABCB1 protein, human
- ATP Binding Cassette Transporter, Subfamily B
- Antineoplastic Agents
- Flavones
- Flutax 2
- Taxoids
- Docetaxel
- Rhodamine 123
- Doxorubicin
- nobiletin
- Paclitaxel
- Fluorouracil
|
Topics |
- ATP Binding Cassette Transporter, Subfamily B
(metabolism)
- Adsorption
- Antineoplastic Agents
(chemistry, pharmacology)
- Apoptosis
(drug effects)
- Cell Cycle
(drug effects)
- Cell Line, Tumor
- Docetaxel
- Doxorubicin
(pharmacology)
- Drug Resistance, Multiple
(drug effects)
- Drug Resistance, Neoplasm
(drug effects)
- Drug Synergism
- Flavones
(chemistry, pharmacology)
- Fluorouracil
(pharmacology)
- Humans
- Intracellular Space
(metabolism)
- Models, Biological
- Molecular Docking Simulation
- Paclitaxel
(pharmacology)
- Rhodamine 123
(metabolism)
- Signal Transduction
(drug effects)
- Taxoids
(pharmacology)
- Treatment Outcome
|